Clinical Trial: A Single Arm, Multicenter Open-Label Interventional to Evaluate the Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07700446) titled 'A Single Arm, Multicenter Open-Label Interventional to Evaluate the Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose' on July 08.

Brief Summary: ReCOUP is a prospective, multicenter, open-label clinical study designed to evaluate the efficacy of upadacitinib (Rinvoq(R)) in patients with ulcerative colitis whose disease has become active again despite maintenance treatment with upadacitinib 30 mg.

This study involves adult patients aged 18 to 64 years with active ulcerative colitis, who are being treated with upadacitinib and are not participating in anothe...